Home Newsfeeds Keybanc Maintains Overweight on Applied Industrial, Lowers Price Target to $130

Keybanc Maintains Overweight on Applied Industrial, Lowers Price Target to $130

Keybanc analyst Ken Newman maintains Applied Industrial (NYSE:AIT) with a Overweight and lowers the price target from $140 to $130.

byBenzinga Newsdesk

September 28, 2022

1 minute read

Keybanc analyst Ken Newman maintains Applied Industrial (NYSE:AIT) with a Overweight and lowers the price target from $140 to $130.

Apple’s Move To Remove Blood Oxygen Feature In US Watches May Affect Sleep Apnea Detection, Says Mark Gurman

By Ananya Gairola

January 21, 9:50 PM

Apple's removal of the blood oxygen tracking feature from its smartwatches could impact its future health-related capabilities, including sleep apnea detection, as highlighted by Mark Gurman.

AAPL

Bank7 Announces Renewal Of Stock Repurchase Plan Of Up To 750,000 Shares

By Benzinga Newsdesk

October 30, 4:47 PM

Bank7 Corp. (NASDAQ:BSVN) ("the Company"), the parent company of Oklahoma City-based Bank7, announced today that its board of directors has authorized a renewal of Bank7's existing stock repurchase program for a term of

BSVN

Chimera Investment Corporation Announces Q2 2023 Common Stock Dividend Of $0.18 And Increase In Share Repurchase Program From $177M To $250M

By Benzinga Newsdesk

June 14, 4:34 PM

Chimera Investment Corporation (NYSE:CIM) (the "Company" or "Chimera") announced today that its Board of Directors declared the second quarter common stock dividend. The Company also announced an increase in the amount

CIM

News

SINOVAC Updates on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection

By Benzinga Newsdesk

September 11, 5:58 AM

Sinovac Biotech Ltd. ("SINOVAC" or the "Company") (NASDAQ:SVA), a leading provider of biopharmaceutical products in China, announced that the Company has completed the phase I clinical trial for its

SVA

Keybanc Maintains Overweight on Applied Industrial, Lowers Price Target to $130

Related Posts

Apple’s Move To Remove Blood Oxygen Feature In US Watches May Affect Sleep Apnea Detection, Says Mark Gurman

Bank7 Announces Renewal Of Stock Repurchase Plan Of Up To 750,000 Shares

Chimera Investment Corporation Announces Q2 2023 Common Stock Dividend Of $0.18 And Increase In Share Repurchase Program From $177M To $250M

SINOVAC Updates on the Clinical Trial Progress of its Anti-COVID-19 Antibody SA55 Injection